In women’s health, Teva's aim is to improve the quality of care and quality of life for women of all ages worldwide. We’re doing this with a broad portfolio of solutions in reproductive health, contraception, menopause, and benign gynaecological conditions.
Reproductive health, including infertility and endometriosis, can put massive strain on women themselves and their families. It is estimated that infertility affects one in seven heterosexual couples in the UK and now a greater proportion of people are seeking treatment for such problems.1
The main causes of infertility in the UK are (percent figures indicate approximate prevalence):
For more information on infertility, you can go to the NHS ‘live well’ website:http://www.nhs.uk/livewell/fertility/Pages/Fertilityhome.aspx
There are a range of medical treatments that are able to help the various causes of infertility. These could be: surgical interventions, medicine or assisted-reproductive technologies.
Our range of medicines in Women's Health includes Ovaleap®▼(follitropin alfa)*, a recombinant follicle stimulating hormone for use by women undergoing Assisted Reproduction Technologies (ART).
Find out more about Ovaleap®
We believe that supporting patients with fertility issues is important and also complex. As well as playing our part, we know that charities and other patient organisations provide valuable support too, that's why we also point you in their direction.
We continue to explore opportunities to expand into other treatments for women’s health issues. Our intent remains, as always, to provide patients with the most effective and safest treatments for their diseases.
Our work with patients, and our experience in this area of therapy, means we are really well placed to invest in extensive research into potential medicines to cure or help alleviate the many symptoms of Women’s health conditions to offer patients a wider choice of treatments.
1 https://www.nice.org.uk/guidance/cg156/chapter/Introduction accessed 31/03/16* This medicine is subject to additional monitoring to allow quick identification of new safety information. You can help by reporting any side effects you may get. See www.mhra.gov.uk/yellowcard for how to report side effects.